カテゴリー： QYResearch, 世界

世界のファンコニ貧血薬市場 2019年

【英語タイトル】Global Fanconi Anemia Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X07597）・商品コード：DATA909X07597
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・ファンコニ貧血薬の世界市場概要
・ファンコニ貧血薬の製造コスト構成分析
・ファンコニ貧血薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ファンコニ貧血薬のセグメント分析（種類別）
（エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）
・ファンコニ貧血薬のセグメント分析（用途別）
（病院、診療所、その他）
・ファンコニ貧血薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Abeona Therapeutics Inc、Genethon SA、Novartis AG、）
・ファンコニ貧血薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fanconi Anemia Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abeona Therapeutics Inc
Genethon SA
Novartis AG
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Eltrombopag Olamine
EXG-34217
Fancalen
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Fanconi Anemia Drug
1.1 Definition of Fanconi Anemia Drug
1.2 Fanconi Anemia Drug Segment by Type
1.2.1 Global Fanconi Anemia Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Eltrombopag Olamine
1.2.3 EXG-34217
1.2.4 Fancalen
1.2.5 Others
1.3 Fanconi Anemia Drug Segment by Applications
1.3.1 Global Fanconi Anemia Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Fanconi Anemia Drug Overall Market
1.4.1 Global Fanconi Anemia Drug Revenue (2014-2025)
1.4.2 Global Fanconi Anemia Drug Production (2014-2025)
1.4.3 North America Fanconi Anemia Drug Status and Prospect (2014-2025)
1.4.4 Europe Fanconi Anemia Drug Status and Prospect (2014-2025)
1.4.5 China Fanconi Anemia Drug Status and Prospect (2014-2025)
1.4.6 Japan Fanconi Anemia Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Fanconi Anemia Drug Status and Prospect (2014-2025)
1.4.8 India Fanconi Anemia Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Fanconi Anemia Drug
2.3 Manufacturing Process Analysis of Fanconi Anemia Drug
2.4 Industry Chain Structure of Fanconi Anemia Drug

3 Development and Manufacturing Plants Analysis of Fanconi Anemia Drug
3.1 Capacity and Commercial Production Date
3.2 Global Fanconi Anemia Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Fanconi Anemia Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Fanconi Anemia Drug Production and Capacity Analysis
4.2 Fanconi Anemia Drug Revenue Analysis
4.3 Fanconi Anemia Drug Price Analysis
4.4 Market Concentration Degree

5 Fanconi Anemia Drug Regional Market Analysis
5.1 Fanconi Anemia Drug Production by Regions
5.1.1 Global Fanconi Anemia Drug Production by Regions
5.1.2 Global Fanconi Anemia Drug Revenue by Regions
5.2 Fanconi Anemia Drug Consumption by Regions
5.3 North America Fanconi Anemia Drug Market Analysis
5.3.1 North America Fanconi Anemia Drug Production
5.3.2 North America Fanconi Anemia Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Fanconi Anemia Drug Import and Export
5.4 Europe Fanconi Anemia Drug Market Analysis
5.4.1 Europe Fanconi Anemia Drug Production
5.4.2 Europe Fanconi Anemia Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Fanconi Anemia Drug Import and Export
5.5 China Fanconi Anemia Drug Market Analysis
5.5.1 China Fanconi Anemia Drug Production
5.5.2 China Fanconi Anemia Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Fanconi Anemia Drug Import and Export
5.6 Japan Fanconi Anemia Drug Market Analysis
5.6.1 Japan Fanconi Anemia Drug Production
5.6.2 Japan Fanconi Anemia Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Fanconi Anemia Drug Import and Export
5.7 Southeast Asia Fanconi Anemia Drug Market Analysis
5.7.1 Southeast Asia Fanconi Anemia Drug Production
5.7.2 Southeast Asia Fanconi Anemia Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Fanconi Anemia Drug Import and Export
5.8 India Fanconi Anemia Drug Market Analysis
5.8.1 India Fanconi Anemia Drug Production
5.8.2 India Fanconi Anemia Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Fanconi Anemia Drug Import and Export

6 Fanconi Anemia Drug Segment Market Analysis (by Type)
6.1 Global Fanconi Anemia Drug Production by Type
6.2 Global Fanconi Anemia Drug Revenue by Type
6.3 Fanconi Anemia Drug Price by Type

7 Fanconi Anemia Drug Segment Market Analysis (by Application)
7.1 Global Fanconi Anemia Drug Consumption by Application
7.2 Global Fanconi Anemia Drug Consumption Market Share by Application (2014-2019)

8 Fanconi Anemia Drug Major Manufacturers Analysis
8.1 Abeona Therapeutics Inc
8.1.1 Abeona Therapeutics Inc Fanconi Anemia Drug Production Sites and Area Served
8.1.2 Abeona Therapeutics Inc Product Introduction, Application and Specification
8.1.3 Abeona Therapeutics Inc Fanconi Anemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Genethon SA
8.2.1 Genethon SA Fanconi Anemia Drug Production Sites and Area Served
8.2.2 Genethon SA Product Introduction, Application and Specification
8.2.3 Genethon SA Fanconi Anemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis AG
8.3.1 Novartis AG Fanconi Anemia Drug Production Sites and Area Served
8.3.2 Novartis AG Product Introduction, Application and Specification
8.3.3 Novartis AG Fanconi Anemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served

9 Development Trend of Analysis of Fanconi Anemia Drug Market
9.1 Global Fanconi Anemia Drug Market Trend Analysis
9.1.1 Global Fanconi Anemia Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Fanconi Anemia Drug Regional Market Trend
9.2.1 North America Fanconi Anemia Drug Forecast 2019-2025
9.2.2 Europe Fanconi Anemia Drug Forecast 2019-2025
9.2.3 China Fanconi Anemia Drug Forecast 2019-2025
9.2.4 Japan Fanconi Anemia Drug Forecast 2019-2025
9.2.5 Southeast Asia Fanconi Anemia Drug Forecast 2019-2025
9.2.6 India Fanconi Anemia Drug Forecast 2019-2025
9.3 Fanconi Anemia Drug Market Trend (Product Type)
9.4 Fanconi Anemia Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Fanconi Anemia Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Fanconi Anemia Drug
Table Global Fanconi Anemia Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Fanconi Anemia Drug Production Market Share by Types in 2018
Figure Eltrombopag Olamine Product Picture
Figure EXG-34217 Product Picture
Figure Fancalen Product Picture
Figure Others Product Picture
Table Global Fanconi Anemia Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Fanconi Anemia Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Fanconi Anemia Drug Revenue (Million USD) (2014-2025)
Figure Global Fanconi Anemia Drug Production (K Pcs) (2014-2025)
Figure North America Fanconi Anemia Drug Market Size (Million USD) (2014-2025)
Figure Europe Fanconi Anemia Drug Market Size (Million USD) (2014-2025)
Figure China Fanconi Anemia Drug Market Size (Million USD) (2014-2025)
Figure Japan Fanconi Anemia Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Fanconi Anemia Drug Market Size (Million USD) (2014-2025)
Figure India Fanconi Anemia Drug Market Size (Million USD) (2014-2025)
Table Fanconi Anemia Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Fanconi Anemia Drug in 2018
Figure Manufacturing Process Analysis of Fanconi Anemia Drug
Figure Industry Chain Structure of Fanconi Anemia Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Fanconi Anemia Drug Manufacturing Plants Distribution
Table Fanconi Anemia Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Fanconi Anemia Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Fanconi Anemia Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Fanconi Anemia Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Fanconi Anemia Drug Production Share by Manufacturers in 2018
Table Fanconi Anemia Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Fanconi Anemia Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Fanconi Anemia Drug Revenue Share by Manufacturers in 2018
Table Fanconi Anemia Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Fanconi Anemia Drug Production by Regions 2014-2019 (K Pcs)
Table Global Fanconi Anemia Drug Production Market Share by Regions 2014-2019
Figure Global Fanconi Anemia Drug Production Market Share by Regions in 2018
Table Global Fanconi Anemia Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Fanconi Anemia Drug Revenue Market Share by Regions 2014-2019
Figure Global Fanconi Anemia Drug Revenue Market Share by Regions in 2018
Table Global Fanconi Anemia Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Fanconi Anemia Drug Consumption Market Share by Regions 2014-2019
Figure North America Fanconi Anemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Fanconi Anemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Fanconi Anemia Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Fanconi Anemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Fanconi Anemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Fanconi Anemia Drug Production, Consumption Import and Export (K Pcs)
Figure China Fanconi Anemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Fanconi Anemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Fanconi Anemia Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Fanconi Anemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Fanconi Anemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Fanconi Anemia Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Fanconi Anemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Fanconi Anemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Fanconi Anemia Drug Production, Consumption Import and Export (K Pcs)
Figure India Fanconi Anemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Fanconi Anemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Fanconi Anemia Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Fanconi Anemia Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Fanconi Anemia Drug Market Share by Application (2014-2019)
Table Abeona Therapeutics Inc Fanconi Anemia Drug Production Sites and Area Served
Table Abeona Therapeutics Inc Fanconi Anemia Drug Product Introduction, Application and Specification
Table Abeona Therapeutics Inc Fanconi Anemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abeona Therapeutics Inc Fanconi Anemia Drug Production Growth Rate (2014-2019)
Table Abeona Therapeutics Inc Fanconi Anemia Drug Production Market Share (2014-2019)
Figure Abeona Therapeutics Inc Fanconi Anemia Drug Revenue Market Share (2014-2019)
Table Abeona Therapeutics Inc Fanconi Anemia Drug Main Business and Markets Served
Table Genethon SA Fanconi Anemia Drug Production Sites and Area Served
Table Genethon SA Fanconi Anemia Drug Product Introduction, Application and Specification
Table Genethon SA Fanconi Anemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genethon SA Fanconi Anemia Drug Production Growth Rate (2014-2019)
Table Genethon SA Fanconi Anemia Drug Production Market Share (2014-2019)
Figure Genethon SA Fanconi Anemia Drug Revenue Market Share (2014-2019)
Table Genethon SA Fanconi Anemia Drug Main Business and Markets Served
Table Novartis AG Fanconi Anemia Drug Production Sites and Area Served
Table Novartis AG Fanconi Anemia Drug Product Introduction, Application and Specification
Table Novartis AG Fanconi Anemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Fanconi Anemia Drug Production Growth Rate (2014-2019)
Table Novartis AG Fanconi Anemia Drug Production Market Share (2014-2019)
Figure Novartis AG Fanconi Anemia Drug Revenue Market Share (2014-2019)
Table Novartis AG Fanconi Anemia Drug Main Business and Markets Served
Figure Global Fanconi Anemia Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Fanconi Anemia Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Fanconi Anemia Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Fanconi Anemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Fanconi Anemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Fanconi Anemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Fanconi Anemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Fanconi Anemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Fanconi Anemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Fanconi Anemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Fanconi Anemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Fanconi Anemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Fanconi Anemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Fanconi Anemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Fanconi Anemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Fanconi Anemia Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Fanconi Anemia Drug by Application (2019-2025)
Table Fanconi Anemia Drug Distributors List
Table Fanconi Anemia Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abeona Therapeutics Inc、Genethon SA、Novartis AG、

★調査レポート[世界のファンコニ貧血薬市場 2019年] (コード：DATA909X07597)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のファンコニ貧血薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 腎性貧血治療の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101594 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、腎性貧血治療の世界市場について調べ、まとめました。種類別セグメントは、鉄分補給、赤血球刺激剤等、用途別セグメントは、病院、薬局、研究所、その他等に区分しました。腎性貧血治療の世界市場概観、メーカー動向、メーカー別腎性貧血治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腎性貧血治療の市場概観 ・腎性貧血治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腎性貧血治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・腎性貧血治療の世界市場規模 ・腎性貧血治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・腎性貧血治療のアメリカ市場規模推移 ・腎性貧血治療のカナダ市場規模推移 ・腎性貧血治療のメキシコ市場規模推移 ・腎性貧血治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Anemia is a common complication of CKD, typically occurring early in the development of the disease and becoming more severe as CKD progresses. The primary treatment goal in renal anemia is to increase and maintain hemoglobin and other anemia parameters, such as ferritin. Scope of the Report: The worldwide market for Renal Anemia Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Renal Anemia Treatment in...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆